Successful treatment with intermediate dose cytosine arabinoside for myelodysplastic syndrome with acute myelofibrosis

Leuk Lymphoma. 2003 May;44(5):891-2. doi: 10.1080/1042819031000067927.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acute Disease
  • Cytarabine / administration & dosage*
  • Humans
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes / complications
  • Myelodysplastic Syndromes / drug therapy*
  • Primary Myelofibrosis / complications
  • Primary Myelofibrosis / drug therapy*
  • Remission Induction / methods
  • Treatment Outcome

Substances

  • Cytarabine